Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pittelli (Parma (PR), Italy), P. Caruso (Parma (PR), Italy), M. Faietti (Parma (PR), Italy), V. Pitozzi (Parma (PR), Italy), S. Pontis (Parma (PR), Italy), M. Bonatti (Parma (PR), Italy), B. Pioselli (Parma (PR), Italy), C. Frati (Parma (PR), Italy), D. Madeddu (Parma (PR), Italy), F. Quaini (Parma (PR), Italy), C. Lagrasta (Parma (PR), Italy), M. Civelli (Parma (PR), Italy), S. Catinella (Parma (PR), Italy), G. Villetti (Parma (PR), Italy), M. Trevisani (Parma (PR), Italy). Comparative analysis of collagen quantification in the bleomycin mouse model of lung fibrosis. 3544

Member's Comments

No comment yet.

Related content which might interest you: Quantitation of hydroxyproline in a mouse model of bleomycin-induced lung fibrosis: comparison with histological analysis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Time-course analysis of bleomycin-induced lung fibrosis in the rat Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Automated histological image analysis for the assessment of bleomycin-induced pulmonary fibrosis in rodents Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation versus fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 396s Year: 2006 High-plex immunofluorescence single cell analysis of fibrotic murine lung on tissue microarrays Source: Virtual Congress 2020 – Cellular involvement in lung injury Year: 2020 Gene expression and cellular profiling in a rat bleomycin model of drug-induced interstitial lung disease (DIILD) Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Effect of Nintedanib in a rat model of lung fibrosis induced by single or double bleomycin administration Source: International Congress 2017 – The wide spectrum of ILDs Year: 2017 PBI-compound, a novel first-in-class anti-fibrotic compound, inhibits CTGF and collagen production in murine and human fibroblasts, and reduces lung fibrosis in the bleomycin-induced lung fibrosis model Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013? Year: 2013 Correlation of Nintedanib efficacy on fibrotic lesion deposition and lung function within a rat IPF model Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Time course analysis of lung function and morphometric parameters in a murine model of emphysema Source: Annual Congress 2011 - Novel mechanisms in lung injury Year: 2011 Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 A longitudinal characterization of lymphangiogenesis in bleomycin-induced pulmonary fibrosis mouse model Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Comparative effects of inhaled and intravenous mesenchymal stem cells in bleomycin-induced pulmonary fibrosis in rabbits Source: Annual Congress 2013 –Cutting edge: drug delivery to the airways Year: 2013 A comparative study of extracelular matrix remodeling in two murine models of emphysema Source: Annual Congress 2010 - Proteases and the matrix Year: 2010 Multiplex and gene expression analysis in a model of smoke induced lung inflammation in mice Source: Eur Respir J 2005; 26: Suppl. 49, 104s Year: 2005